Dynamic Technology Lab’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Dynamic Technology Lab’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-18,194	Closed	-$150K	–	1643
2021 Q2	$150K	Sell	18,194 -5,172	-22%	-$44K	0.02%	969
2021 Q1	$209K	Buy	+23,366	New	+$268K	0.02%	935
2020 Q4	–	Sell	-14,627	Closed	-$152K	–	1482
2020 Q3	$152K	Sell	14,627 -22,641	-61%	-$277K	0.02%	845
2020 Q2	$490K	Buy	+37,268	New	+$386K	0.07%	448
2019 Q3	–	Sell	-10,055	Closed	-$124K	–	1411
2019 Q2	$124K	Sell	10,055 -4,916	-33%	-$56.7K	0.02%	864
2019 Q1	$187K	Buy	+14,971	New	+$200K	0.03%	842
2018 Q4	–	Sell	-11,597	Closed	-$217K	–	1433
2018 Q3	$217K	Buy	+11,597	New	+$266K	0.03%	861
2016 Q3	–	Sell	-11,970	Closed	-$179K	–	1244
2016 Q2	$179K	Buy	+11,970	New	+$150K	0.05%	736

Other funds holding FLXN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dynamic Technology Lab's FLXN Position: Q3 2021 in Review

Dynamic Technology Lab sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2021, closing a stake of 18,194 shares — an estimated $150K sold.

Dynamic Technology Lab first reported a position in FLXN in Q2 2016 and held it in 8 quarters. The position peaked at $490K in Q2 2020. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

Dynamic Technology Lab reported no remaining Flexion Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
Dynamic Technology Lab sold 18,194 Flexion Therapeutics, Inc. shares in Q3 2021, an estimated $150K.
Dynamic Technology Lab first reported a position in Flexion Therapeutics, Inc. in Q2 2016 and held it in 8 quarters.
Dynamic Technology Lab's Flexion Therapeutics, Inc. position peaked at $490K in Q2 2020.
145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on Dynamic Technology Lab's 13F filing for Q3 2021, filed 15 Nov 2021.